Pharming announces public cash offer to the shareholders of Abliva AB
Global Newswire by Notified: M&A
DECEMBER 15, 2024
Proposed acquisition strengthens Pharmings late-stage pipeline with a potential first-in-disease asset Ablivas lead product KL1333 is currently in a.
Let's personalize your content